Open AccessComparison of the safety and prognosis of sequential regorafenib after sorafenib and lenvatinib treatment failure in patients with unresectable hepatocellular carcinoma: a retrospective cohort study
Author(s) -
Jian Zhai,
Jianwei Liu,
Zhigang Fu,
Shilei Bai,
Xiaowei Li,
Zengqiang Qu,
Yanfu Sun,
Ruiliang Ge,
Feng Xue
Publication year - 2022
Publication title -
journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.084
H-Index - 39
eISSN - 2219-679X
pISSN - 2078-6891
DOI - 10.21037/jgo-22-404
Subject(s) - lenvatinib , sorafenib , medicine , regorafenib , hepatocellular carcinoma , adverse effect , oncology , incidence (geometry) , gastroenterology , cancer , colorectal cancer , physics , optics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom